RBGLY LAWSUIT ALERT: Levi & Korsinsky Notifies Reckitt Benckiser Group plc Investors of a Class Action Lawsuit and Upcoming Deadline

Core Viewpoint - A class action securities lawsuit has been filed against Reckitt Benckiser Group plc, alleging securities fraud that negatively impacted investors between January 13, 2021, and July 28, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Reckitt Benckiser's cow's milk-based formula, Enfamil, posed an increased risk of NEC (Necrotizing Enterocolitis) in preterm infants, which was not disclosed [2]. - It is alleged that the company misrepresented the impact of these risks on its sales and legal exposure, leading to materially false and misleading statements about its business and prospects [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until August 4, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions of dollars for shareholders and being recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4].